Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects

NCT00916110 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103
DRUG: ATN-103

Sponsor

Ablynx, a Sanofi company